Chemistry: molecular biology and microbiology – Vector – per se
Patent
1995-10-06
1998-10-20
Chambers, Jasemine C.
Chemistry: molecular biology and microbiology
Vector, per se
514 44, 4351723, C12N 1500
Patent
active
058245448
ABSTRACT:
The present invention relates to novel adenovirus vectors for use in gene therapy which are designed to prevent the generation of replication-competent adenovirus (RCA) during in vitro propagation and clinical use. The invention also provides methods for the production of the novel virus vectors. These vectors maximize safety for clinical applications in which adenovirus vectors are used to transfer genes into recipient cells for gene therapy.
REFERENCES:
Zabner et al., Gene Therapy 3:458-465, 1996.
Armentano et al., Human Gene Therapy 6:1343-1353, 1995.
Krougliak et al., Human Gene Therapy 6:1575-1586, 1995.
Welsh et al., Human Gene Therapy 6:205-218, 1995.
Wadsworth et al., J. Cell Biochem. Supp. 21A, Abtstract No. C6-450, 1995.
Setoguchi et al., Blood 84:2946-2953, 1994.
Engelhardt et al., Human Gene Therapy 5:1217-1229, 1994.
Armentano et al., J. Cell Biochem. Supp. 18A, Abstract No. DZ 102, 1994.
Wilkinson et al., Nucleic Acids Res. 20:2233-2239, 1992.
Rosenfeld et al., Cell 68:145-155, 1992.
Jolly, D., Cancer Gene Therapy 1:51-64, 1994.
Hodgson, C.P., BioTechnology 13:222-225, 1995.
Horwitz, M.S., "Adenoviridae and Their Replication," in Virology, 2nd edition, Fields, B.N., et al., eds., Raven Press, New York, 1990.
Berkner, K.L., Curr. Top. Micro. Immunol. 158:39-66, 1992.
Graham, F.L., J. Gen. Virol. 36:59-72, 1977.
Vincent et al., Nature Genetics 5:130-134, 1993.
Descamps et al., Human Gene Therapy 5:979-985, 1994.
Stratford-Perricaudet et al., Human Gene Therapy 1:241-256, 1990.
Mitani et al., Human Gene Therapy 5:941-948, 1994.
Haddada et al., Human Gene Therapy 4:703-711, 1993.
Jaffe et al., Nature Genetics 1:372-378, 1992.
Zabner, J. et al., Nature Genetics 6:75-83, 1994.
Rich, D. et al., Human Gene Therapy 4:461-476, 1993.
Zabner, J. et al., Cell 75:207-216, 1993.
Crystal, R.G. et al., Nature Genetics 8:42-51, 1994.
Bridge, E. et al., J. Virol. 63:631-638, 1989.
Huang, M. et al., J. Virol. 63:2605-2615, 1989.
Klessig, D. et al., Mol. Cell. Biol. 4:1354-1362, 1984.
Weinberg, D. et al., Proc. Natl. Acad. Sci. USA 80:5383-5386, 1983.
Ghosh-Choudhury et al., J. EMBO 6:1733-1739, 1987.
Hehir et al., Pediatr. Pulmon., Supp. 12, 1995, Abstract.
Marshall, Science, 269, 1995, 1050-1055.
Miller, FASEB J., 9, 1995, 190-199.
Culver et al., Trends in Genetics, 10(5), 1994, 174-178.
Hodgson, Exp. Opin. Ther. Pat., 5(5), 1995, 458-469.
Neve, Trends Neuroscience, 16(7), 1993, 251-253.
Berkner, BioTechniques, 6(7), 1988, 616-629.
Wills et al., Human Gene Therapy, 5, 1994, 1079-1088.
Armentano Donna
Romanczuk Helen
Wadsworth Samuel Charles
Chambers Jasemine C.
Clark Deborah J. R.
Genzyme Corporation
LandOfFree
Adenovirus vectors for gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenovirus vectors for gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenovirus vectors for gene therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-243541